Medical Issues in Social Security Disability
Select a format
Select subscription type
Terms & conditions
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing firstname.lastname@example.org; or returning the invoice marked "CANCEL".
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
REVISION 20 HIGHLIGHTS
This 20th revision of Medical Issues in Social Security Disability adds new sections and updates throughout, including updates to various listing discussions that address evaluations in light of SARS-CoV-2 (COVID-19) infection. New and updated sections include:
New and Updated
- Chapter 1, §1.16.1.a, §1.16.2, spinal stenosis prevalence and RFC.
- Chapter 1, §1.15.1.a, the effectiveness of spinal cord stimulation for relief of back pain.
- Chapter 1, §1.15.2, psychological treatment (“pain reprocessing”) for chronic low back pain.
- Chapter 2, §2.07.1.a, vestibular schwannomas and prognosis after surgery.
- Chapter 4, §4.01.1.b, coronary artery calcium score
- Chapter 4, §4.02.1.a, COVID-19 long term cardiovascular effects.
- Chapter 5, §5.06.1.a, inflammatory bowel disease being accompanied by psychological problems through effect on choroid plexus of brain from inflammatory products of IBD.
- Chapter 7, §7.08.1.a, possible upcoming genetic treatment for hemophilia A and B.
- Chapter 7, §7.08.2, fatigue from idiopathic thrombocytopenia purpura.
- Chapter 8, §8.06.1.a, surgical results for hidradenitis suppurativa.
- Chapter 11, §11.14.1.a, Long COVID producing peripheral neuropathy.
- Chapter 11, § 11.09.1.a, the importance of recognizing clinical worsening in relapsing-remitting multiple sclerosis in the absence of new MRI brain inflammatory lesions, because these individuals still have progressive brain atrophy.
- Chapter 11, §11.09.1.a, the cause of multiple sclerosis being strongly associated with the Epstein-Barr virus.
- Chapter 12, §12.02.3, COVID-19 infection evidence for brain damage.
- Chapter 12, §12.02.1.a, the new Lumipulse test to aid in the diagnosis of Alzheimer’s disease that may appear in medical records.
- Chapter 13, §13.24.1.a, § 13.24.2, prostate cancer.
- Chapter 14, §14.02.1.a, discovery of the defective gene that causes most or all of systemic lupus cases.
eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® for further legal research options. A valid subscription to Lexis+® is required to access this content.